Q16655 (MAR1_HUMAN) Homo sapiens (Human)

Melanoma antigen recognized by T-cells 1 UniProtKBInterProSTRINGInteractive Modelling

118 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: A0A384MR46; Pan troglodytes: A0A6D2Y8E9, A0A2J8M4U8; Pan paniscus: A0A2R9BLB0; Gorilla gorilla gorilla: G3RJG3

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1 Heteromer
P01903; P01911;
100-114
Assess
Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant epitope Heteromer
P04439; P61769;
26-35
GOL;
Assess
Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide Heteromer
P04439; P61769;
26-35
GOL;NA;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; P61769;
26-35
Assess
Structure determination of an enhanced affinity TCR, a24b17, in complex with HLA-A*02:01 presenting… Heteromer
A0A5B8RNS7; P61769;
26-35
GOL;EDO;SO4;TAM;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; P61769;
26-35
Assess
MA2-MART1-HLAA0201 Heteromer
A0A140T9X5; P61769;
26-35
GOL;
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; P61769;
26-35
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P04439; P61769;
26-35
EPE;SO4;
Assess
RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 Heteromer
A0A075B6T6; A0A0K0K1A5; P04439; P61769;
26-35
Assess
The complex between high affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
P04439; P61769;
26-35
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… Heteromer
P01848; P04439; P61769;
26-35
Assess
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… Heteromer
A0A075B6T6; A0A1B0GXE1; K7N5M4; P01848; P04439; P61769;
26-35
Assess
Structural basis for ineffective T-cell responses to MHC anchor residue improved heteroclitic pepti… Heteromer
P04439; P61769;
26-35
EDO;
Assess
Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor Heteromer
P01848; P01850; P61769; Q8WLS4;
26-35
GOL;SO4;
Assess
human 199.54-16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6T6; A0A0C4ZKA8; A0A5B3; K7N5N2; P04439; P61769;
26-35
SCN;K;CL;
Assess
MHC Class I A02 Allele presenting EAAGIGILTV, in complex with Mel8 TCR Heteromer
A0A140T913; P61769;
26-35
EDO;
Assess
human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6N1; P01848; P04439; P61769;
26-35
NA;
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L su… Heteromer
P04439; P61769;
27-35
GOL;FMT;NA;
Assess
Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide Heteromer
P04439; P61769;
27-35
GOL;NA;
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L su… Heteromer
P04439; P61769;
27-35
GOL;NA;
Assess
Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide Heteromer
P04439; P61769;
27-35
GOL;
Assess
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
K7N5M3; K7N5M4; P04439; P61769;
27-35
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P04439; P61769;
27-35
Assess
The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide Heteromer
P04439; P61769;
27-35
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6jxr.1.Cmonomer0.7422-52
25.81
Assess